Status:
COMPLETED
Effectiveness of Various Smoking Cessation Therapies in Reducing Smoking in Adolescents - 1
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Conditions:
Smoking Cessation
Tobacco Use Disorder
Eligibility:
All Genders
13-18 years
Phase:
PHASE2
Brief Summary
Currently one in five high school students smokes. Smoking can harm adolescents well before they reach adulthood by causing a number of immediate, sometimes irreversible, health risks and problems. Th...
Detailed Description
Among adolescents, the short-term health effects of smoking include damage to the respiratory system, addiction to nicotine, and the associated risk of other drug use. Adolescents are at greater risk ...
Eligibility Criteria
Inclusion
- At least 6 months of daily cigarette smoking
- No use of other tobacco products
- Motivated to reduce or quit smoking
- Not currently using medications to quit smoking
- Agree to use an effective form of contraception throughout the study
Exclusion
- People for whom use of nicotine replacement therapy or bupropion is medically inadvisable
- History of alcohol or drug abuse within 6 months of enrollment
- History of emotional problems (as assessed by the Adolescent Symptoms Inventory) within 6 months prior to enrollment
- Currently on an unstable dose of psychoactive medications
- Currently taking medications that may react with one of the treatment medications
- Pregnant
Key Trial Info
Start Date :
April 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2004
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT00158171
Start Date
April 1 2002
End Date
May 1 2004
Last Update
January 10 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota
Minneapolis, Minnesota, United States, 55455